Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Monteferrario

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Haematologica|August 24, 2014
High expression of transcription factor 4 (TCF4) is an independent adverse prognostic factor in acute myeloid leukemia that could guide treatment decisionsFlorentien E M in 't Hout, Bert A van der Reijden, Davide Monteferrario, et al.
Blood|May 5, 2012
Improved classification of MLL-AF9-positive acute myeloid leukemia patients based on BRE and EVI1 expressionSylvie M Noordermeer, Davide Monteferrario, Mathijs A Sanders, et al.
The EMBO Journal|August 7, 2012
The E3 ligase HOIP specifies linear ubiquitin chain assembly through its RING-IBR-RING domain and the unique LDD extensionJudith J Smit, Davide Monteferrario, Sylvie M Noordermeer, et al.
Biology Open|December 6, 2012
Identification of the ubiquitin ligase Triad1 as a regulator of endosomal transportGerco Hassink, Johan Slotman, Viola Oorschot, et al.
Molecular Therapy. Methods & Clinical Development|October 4, 2023
Production of therapeutic levels of human FIX-R338L by engineered B cells using GMP-compatible mediumMarion David, Davide Monteferrario, Gaëlle Saviane, et al.
Experimental Hematology|October 14, 2018
TCF4 promotes erythroid developmentFlorentien E M In 't Hout, Jolanda van Duren, Davide Monteferrario, et al.
Molecular Therapy. Oncology|June 9, 2025
Enhanced anti-tumor activity by zinc finger repressor-driven epigenetic silencing of immune checkpoints and TGFBR2 in CAR-T cells and TILsMarion David, Phillip Schiele, Davide Monteferrario, et al.
Molecular Therapy. Methods & Clinical Development|May 8, 2024
Epigenetic control of multiple genes with a lentiviral vector encoding transcriptional repressors fused to compact zinc finger arraysDavide Monteferrario, Marion David, Satish K Tadi, et al.
The New England Journal of Medicine|December 12, 2013
A dominant-negative GFI1B mutation in the gray platelet syndromeDavide Monteferrario, Nikhita A Bolar, Anna E Marneth, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Haematologica|August 24, 2014
High expression of transcription factor 4 (TCF4) is an independent adverse prognostic factor in acute myeloid leukemia that could guide treatment decisionsFlorentien E M in 't Hout, Bert A van der Reijden, Davide Monteferrario, et al.
Blood|May 5, 2012
Improved classification of MLL-AF9-positive acute myeloid leukemia patients based on BRE and EVI1 expressionSylvie M Noordermeer, Davide Monteferrario, Mathijs A Sanders, et al.
The EMBO Journal|August 7, 2012
The E3 ligase HOIP specifies linear ubiquitin chain assembly through its RING-IBR-RING domain and the unique LDD extensionJudith J Smit, Davide Monteferrario, Sylvie M Noordermeer, et al.
Biology Open|December 6, 2012
Identification of the ubiquitin ligase Triad1 as a regulator of endosomal transportGerco Hassink, Johan Slotman, Viola Oorschot, et al.
Molecular Therapy. Methods & Clinical Development|October 4, 2023
Production of therapeutic levels of human FIX-R338L by engineered B cells using GMP-compatible mediumMarion David, Davide Monteferrario, Gaëlle Saviane, et al.
Experimental Hematology|October 14, 2018
TCF4 promotes erythroid developmentFlorentien E M In 't Hout, Jolanda van Duren, Davide Monteferrario, et al.
Molecular Therapy. Oncology|June 9, 2025
Enhanced anti-tumor activity by zinc finger repressor-driven epigenetic silencing of immune checkpoints and TGFBR2 in CAR-T cells and TILsMarion David, Phillip Schiele, Davide Monteferrario, et al.
Molecular Therapy. Methods & Clinical Development|May 8, 2024
Epigenetic control of multiple genes with a lentiviral vector encoding transcriptional repressors fused to compact zinc finger arraysDavide Monteferrario, Marion David, Satish K Tadi, et al.
The New England Journal of Medicine|December 12, 2013
A dominant-negative GFI1B mutation in the gray platelet syndromeDavide Monteferrario, Nikhita A Bolar, Anna E Marneth, et al.
Pageof 1